Euretina Congress
Euretina Congress
October 05, 2018
1 min watch
Save

VIDEO: Topical treatment of AMD shows promise in early stages of clinical trial

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

VIENNA — At the Euretina meeting, Hemal Mehta, MD, speaks about the early results of the PanOptica clinical trial on a new molecule for the topical treatment of age-related macular degeneration, which could revolutionize the way the disease is treated.